Search results
Results from the WOW.Com Content Network
Prescription drug monitoring programs, or PDMPs, are an example of one initiative proposed to alleviate effects of the opioid crisis. [1] The programs are designed to restrict prescription drug abuse by limiting a patient's ability to obtain similar prescriptions from multiple providers (i.e. “doctor shopping”) and reducing diversion of controlled substances.
Prescription drug overuse or non-medical prescription drug use is the use of prescription medications that is more than the prescribed amount, regardless of whether the original medical reason to take the drug is legitimate. [1] [2] A prescription drug is a drug substance prescribed by a doctor and intended to for individual use only. [3]
The Oklahoma Bureau of Narcotics and Dangerous Drugs Control (OBN), often shortened to Oklahoma Bureau of Narcotics, is an agency of the government of Oklahoma charged with minimizing the abuse of controlled substances through law enforcement measures directed primarily at drug trafficking, illicit drug manufacturing, and major suppliers of illicit drugs.
It's not a permanent fix, but it's a fix, and advocates for the poor say an infusion of funds in Oklahoma County will fill a need the state wrote off.
Prescription drug addiction is the chronic, repeated use of a prescription drug in ways other than prescribed for, including using someone else’s prescription. [ 3 ] [ 4 ] A prescription drug is a pharmaceutical drug that may not be dispensed without a legal medical prescription .
The National Council for Prescription Drug Programs (NCPDP) is an American nonprofit standards development organization representing most sectors of the U.S. pharmacy services industry. It was founded in 1977 as the extension of a Drug Ad Hoc Committee that made recommendations for the U.S. National Drug Code (NDC). It is based in Scottsdale ...
While receiving opioid therapy, patients should be periodically evaluated for opioid-related complications and clinicians should review state prescription drug monitoring program systems. [18] The latter should be assessed to reduce the risk of overdoses in patients due to their opioid dose or medication combinations. [18]
Arrestee Drug Abuse Monitoring, or ADAM, was a survey conducted by the United States Department of Justice from 1997-2003 and the Office of National Drug Control Policy as ADAM II from 2007-2014 to gauge the prevalence of illegal drug use among arrestees and to track changes in patterns of drug use an availability across regions of the country.